• Home
  • Mutual Funds
  • ICICI Prudential Nifty Pharma Index Fund - Direct Plan Growth

ICICI Prudential Nifty Pharma Index Fund - Direct Plan Growth Return

  • 1M
  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y
This Fund:
Sensex:
BankFD:

Showing Funds Performance since Sep 07, 2020

ICICI Prudential Nifty Pharma Index Fund - Direct Plan Growth Fund Overview

Min. investment

SIP ₹1000 & Lump. ₹1000

AUM (Fund size)

₹130 Cr

Lock In Period

N/A

Expense Ratio

0.38

Exit Load

Nil

Benchmark

Nifty Pharma Total Return

Summary

ICICI Prudential Nifty Pharma Index Fund - Direct Plan Growth NAV is ₹18.9170 as of 21 Jun, 2026. ICICI Prudential Nifty Pharma Index Fund - Direct Plan Growth has delivered 83.33% returns since its launch. The minimum SIP investment amount in ICICI Prudential Nifty Pharma Index Fund - Direct Plan Growth is ₹1000. The AUM of ICICI Prudential Nifty Pharma Index Fund - Direct Plan Growth is ₹130 Cr. The expense ratio of the fund is 0.38%, and its benchmark is Nifty Pharma Total Return. The current exit load of the fund is Nil. In the last 1M months, ICICI Prudential Nifty Pharma Index Fund - Direct Plan Growth has delivered -1.88% returns.

ICICI Prudential Nifty Pharma Index Fund - Direct Plan Growth Calculate Returns

You would have got

close_grey_icon
No Data Found
Your Investment Amount
  • 1
  • 2
  • 3
  • 4
  • 5

Growth Review

DurationFund Return(%)Category Average(%)Category Best(%)
1M-1.88-0.6611.43
6M7.710.9438.47
1Y12.813.92117.55
3Y22.3911.78222.99

Portfolio Analysis

  • Equity: 99.50%
  • Debt: 0.50%
  • Others
As on: 2026-05-31
View allocation % by

1. Sun Pharmaceutical Industries Ltd.21.33%
2. Divi's Laboratories Ltd.9.48%
3. Dr. Reddy's Laboratories Ltd.8.89%
4. Cipla Ltd.8.83%
5. Lupin Ltd.6.16%
6. Laurus Labs Ltd.5.93%
7. Torrent Pharmaceuticals Ltd.5.16%
8. Aurobindo Pharma Ltd.4.46%
9. Glenmark Pharmaceuticals Ltd.3.83%
10. Alkem Laboratories Ltd.3.60%
11. Biocon Ltd.3.43%
12. Zydus Lifesciences Ltd.3.02%
13. Mankind Pharma Ltd.3.01%
14. IPCA Laboratories Ltd.2.37%
15. Gland Pharma Ltd.2.00%
16. J.B.Chemicals & Pharmaceuticals Ltd.1.99%
17. Wockhardt Ltd.1.88%
18. Abbott India Ltd.1.55%
19. Ajanta Pharma Ltd.1.38%
20. Piramal Pharma Ltd.1.20%

About Fund ICICI Prudential Nifty Pharma Index Fund - Direct Plan Growth

ICICI Prudential Nifty Pharma Index Fund - Direct Plan Growth managed by ICICI Prudential Mutual Fund,is a Equity - Index Fundscheme with Assets Under Management of ₹130 Crore. The fund benchmarks its performance against the Nifty Pharma Total Return while maintaining an expense ratio of 0.38. Under the expert guidance of Nishit Patel ,the fund implements a disciplined investment approach aligned with its mandate. The scheme requires a minimum investment of ₹500 for SIP and ₹1,000 for lump sum investments, making it accessible to diverse investor profiles.

Fund Managers

Nishit Patel

Mr. Nishit Patel is a B.Com & Chartered Accountant. ICICI Prudential Asset Management Company Limited - ETF Business - November 2018 - January 2020.

Peer Comparison

No Data Found
No Data Found

ICICI Prudential Nifty Pharma Index Fund - Direct Plan Growth FAQs

ICICI Prudential Nifty Pharma Index Fund - Direct Plan Growth's fund is managed by experienced SEBI-registered investment fund manager , who implements the fund's strategy through research-backed decisions while adhering to its stated objectives.

The expense ratio of ICICI Prudential Nifty Pharma Index Fund - Direct Plan Growth is 0.38. This expense ratio is calculated by dividing the fund's operating expenses by its net assets.

ICICI Prudential Nifty Pharma Index Fund - Direct Plan Growth’s fund performance is as follows:
  • 1 Month : -1.88%
  • 6 Months : 7.71%
  • 1 Year : 12.81%
  • 3 Years : 22.39%
Returns of ICICI Prudential Nifty Pharma Index Fund - Direct Plan Growth are updated daily based on NAV of ₹ 18.9170 as on Jun 19,2026. Since inception, the return has been 83.33%.

You can invest in ICICI Prudential Nifty Pharma Index Fund - Direct Plan Growth through SIP with a minimum of ₹500 monthly or make a lump sum investment of a minimum ₹1,000. Additional purchase minimums vary by scheme.

The fund size (AUM) of ICICI Prudential Nifty Pharma Index Fund - Direct Plan Growth is ₹130 crore. It changes based on market performance, inflows, and outflows.

You can track your investment in ICICI Prudential Nifty Pharma Index Fund - Direct Plan Growth through our website, our Choice FinX mobile app, regular statements, and email updates. Our customer support team is available for queries.